ABCB11 and metabolic dysfunction-associated steatotic liver disease: Reduced BSEP function due to drug-mediated inhibition is one mechanism of DILI.25 Previous reports have suggested an increased DILI risk in the obese and NAFLD populations.7 The BSEPMZA data obtained from our study offer insight into zonal regions potentially more susceptible to DILI in NAFLD.